Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Collier

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
RMD Open|March 14, 2018
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)Philip J Mease, Dafna D Gladman, Ahmed S Samad, et al.
Frontiers in Neurology|July 7, 2022
Using Large-Scale Sensor Data to Test Factors Predictive of Perseverance in Home Movement Rehabilitation: Optimal Challenge and Steady EngagementEdgar De Jesus Ramos Muñoz, Veronica Ann Swanson, Christopher Johnson, et al.
Biomaterials|August 20, 2013
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammationJianjun Chen, Rebecca R Pompano, Felix W Santiago, et al.
ACS Biomaterials Science & Engineering|February 12, 2019
A Supramolecular Vaccine Platform Based on α-Helical Peptide NanofibersYaoying Wu, Pamela K Norberg, Elizabeth A Reap, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2022
Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol CounterpartImran Ozer, Garrett Kelly, Renpeng Gu, et al.
Nature Biomedical Engineering|November 27, 2023
Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibresElizabeth J Curvino, Emily F Roe, Helena Freire Haddad, et al.
Rheumatology Advances in Practice|November 26, 2019
Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort studyGrant W Cannon, Alan R Erickson, Chia-Chen Teng, et al.
Science Advances|August 22, 2020
Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and T<sub>H</sub>17 responsesYouhui Si, Qiaomu Tian, Fan Zhao, et al.
Cell Reports|October 21, 2023
Lung cDC1 and cDC2 dendritic cells priming naive CD8<sup>+</sup> T cells in situ prior to migration to draining lymph nodesYouhui Si, Yihan Wang, Qiaomu Tian, et al.
Rheumatology International|July 20, 2019
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world settingPhilip J Mease, Neil A Accortt, Sabrina Rebello, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
RMD Open|March 14, 2018
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)Philip J Mease, Dafna D Gladman, Ahmed S Samad, et al.
Frontiers in Neurology|July 7, 2022
Using Large-Scale Sensor Data to Test Factors Predictive of Perseverance in Home Movement Rehabilitation: Optimal Challenge and Steady EngagementEdgar De Jesus Ramos Muñoz, Veronica Ann Swanson, Christopher Johnson, et al.
Biomaterials|August 20, 2013
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammationJianjun Chen, Rebecca R Pompano, Felix W Santiago, et al.
ACS Biomaterials Science & Engineering|February 12, 2019
A Supramolecular Vaccine Platform Based on α-Helical Peptide NanofibersYaoying Wu, Pamela K Norberg, Elizabeth A Reap, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2022
Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol CounterpartImran Ozer, Garrett Kelly, Renpeng Gu, et al.
Nature Biomedical Engineering|November 27, 2023
Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibresElizabeth J Curvino, Emily F Roe, Helena Freire Haddad, et al.
Rheumatology Advances in Practice|November 26, 2019
Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort studyGrant W Cannon, Alan R Erickson, Chia-Chen Teng, et al.
Science Advances|August 22, 2020
Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and T<sub>H</sub>17 responsesYouhui Si, Qiaomu Tian, Fan Zhao, et al.
Cell Reports|October 21, 2023
Lung cDC1 and cDC2 dendritic cells priming naive CD8<sup>+</sup> T cells in situ prior to migration to draining lymph nodesYouhui Si, Yihan Wang, Qiaomu Tian, et al.
Rheumatology International|July 20, 2019
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world settingPhilip J Mease, Neil A Accortt, Sabrina Rebello, et al.
Pageof 24